PMS14 A COST-EFFECTIVENESS ANALYSIS OF BIOLOGICAL AGENTS FOR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS FOLLOWING INADEQAUTE RESPONSE TO METHOTREXATE

Autor:	TL Kauf, JJ Spooner, Pranav K. Gandhi, P Viraparia
Rok vydání:	2008
Předmět:	Moderate to severe medicine.medical_specialty business.industry Health Policy Rheumatoid arthritis Internal medicine Public Health Environmental and Occupational Health Medicine Methotrexate Cost-effectiveness analysis business medicine.disease medicine.drug
Zdroj:	Value in Health. 11:A258-A259
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)70816-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d990da842976ba30d26cbd92c4c09d69 https://doi.org/10.1016/s1098-3015(10)70816-0 Zobrazit plný text záznamu Full Text from ScienceDirect Plný text